Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

EBR/SEQUA stock hub

EBR/SEQUA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EBR/SEQUAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

43.6M

Euronext Brussels

Market data

Price

Recent price action with selectable time range.

EBR/SEQUAEBR/SEQUA

—

Loading chart…

In the news

Latest news · EBR/SEQUA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-448.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EBR/SEQUA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

151

Groups with data

Currency

EUR

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Belgium
Country code	BE
Employees	48
Employees Change	-14%
Employees Change Percent	-22.58
Enterprise value	EUR 77.6M
Exchange	Euronext Brussels
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Devices
Isin	BE0974340722
Last refreshed	2026-05-10
Market cap	EUR 43.6M
Price	EUR 0.61
Price currency	EUR
Sector	Healthcare
Sic	3841
Symbol	ebr/SEQUA
Website	https://www.sequanamedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-119.04%
EV Earnings	-1.5x
EV/FCF	-4.39x
FCF yield	-40.62%
P/B ratio	-1.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -355
Net Income	EUR -51.9M
Net Income Growth Years	0%
Profit Per Employee	EUR -1.1M
ROA	-88.4
Roa5y	-100.8
ROCE	47.72
ROIC	-448.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-44.58%
Cagr3y	-43.56%
Cagr5y	-41.08%
EPS Growth Years	0
Revenue Growth	-85.19x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 14.6M
Cash	EUR 7.3M
Current Assets	EUR 10.6M
Current Liabilities	EUR 52.2M
Debt	EUR 41.4M
Debt FCF	EUR -2.34
Equity	EUR -39.2M
Interest Coverage	-1.65
Liabilities	EUR 53.7M
Long Term Assets	EUR 4M
Long Term Liabilities	EUR 1.6M
Net Cash	EUR -34.1M
Net Cash By Market Cap	EUR -78.26
Tangible Book Value	EUR -39.2M
Tangible Book Value Per Share	EUR -0.68
WACC	11.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.2
Inventory Turnover	0
Net Working Capital	EUR -8.2M
Quick ratio	0.15
Working Capital	EUR -41.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-54.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-44.56%
200-day SMA	0.73
3Y total return	-82.03%
50-day SMA	0.53
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.9%
All Time High	12.4
All Time High Change	-95.07%
All Time High Date	2021-01-04
All Time Low	0.46
All Time Low Change	32.83%
All Time Low Date	2026-03-30
ATR	0.02
Beta	-0.29
Beta1y	0.47
Beta2y	2.14
Ch YTD	-3.63
High	0.67
High52	1.62
High52 Date	2025-08-06
High52ch	-62.24%
Low	0.56
Low52	0.46
Low52 Date	2026-03-30
Low52ch	32.83%
Ma50ch	14.29%
Price vs 200-day SMA	-16.62%
RSI	68.92
RSI Monthly	38.6
RSI Weekly	46.93
Sharpe ratio	-0.38x
Sortino ratio	-0.53
Total Return	-54.42%
Tr YTD	-3.63
Tr1m	22.2%
Tr3m	8.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -17.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	43,606,639%
Net Borrowing	18,042,252
Shares Insiders	9.89%
Shares Institutions	18.94%
Shares Out	71,289,225
Shares Qo Q	27.4%
Shares Yo Y	54.42%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -17.9M
Average Volume	164,345.4x
Bv Per Share	-0.68
CAPEX	EUR -66,219
Ch1m	22.2
Ch1y	-44.56
Ch3m	8.33
Ch3y	-82.03
Ch5y	-92.9
Ch6m	-8.26
Change	0%
Change From Open	-8.67
Close	0.61
Days Gap	9.49
Depreciation Amortization	735,195
Dollar Volume	399,074.7
Earnings Date	2026-04-28
EBIT	EUR -17.9M
EBITDA	EUR -17.2M
EPS	EUR -1.11
F Score	2
FCF	EUR -17.7M
FCF EV Yield	-22.79x
FCF Per Share	EUR -0.25
Financing CF	20,850,277
Fiscal Year End	December
Founded	2,006
Income Tax	EUR 260,904
Investing CF	-70,923
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2025-06-30
Ma150	0.62
Ma150ch	-0.92%
Ma20	0.56
Ma20ch	10.05%
Net CF	3,160,922
Next Earnings Date	2026-06-25
Open	0.67
Position In Range	46.79
Ppne	1,866,346
Price Date	2026-04-28
Relative Volume	3.74x
Share Based Comp	187,164
Tr6m	-8.26%
Volume	653,150
Z Score	-32.69

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EBR/SEQUA pay a dividend?

Capital-return profile for this ticker.

Performance

EBR/SEQUA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EBR/SEQUA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.9%

Share of float held by funds and institutions

Insider ownership

+9.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+54.4%

Negative means the company is buying back shares.

Technical

EBR/SEQUA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.9

Neutral momentum band

Price vs 200-day MA

-16.6%

50/200-day relationship not available

Beta (5Y)

-0.29

Less volatile than the market

Sharpe ratio

-0.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EBR/SEQUA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ebr/SEQUA stock rating?

ebr/SEQUA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ebr/SEQUA analysis?

The full report lives at /stocks/ebr/SEQUA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ebr/SEQUA?

The latest report frames ebr/SEQUA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ebr/SEQUA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.